MBX Biosciences (MBX) announced the appointment of Steve Hoerter as an independent director to the Company’s Board of Directors. Hoerter previously served as President, CEO and Director of ...

Citizens JMP initiated coverage of MBX Biosciences (MBX) with an Outperform rating and $38 price target MBX is using its proprietary Precision ...

CARMEL, Ind., April 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...

So should MBX Biosciences (NASDAQ:MBX) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to ...

CARMEL, Ind., April 07, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...